Moreover, cancer cells with low ROS levels have a tendency to express more P-gp in the cell membrane, as demonstrated by the positive association between Nrf2 and P-gp expression; accordingly, most DOX-resistant cancer cells showed Nrf2 overexpression [70,72]. This evidence concerns the gene NFE2L2 and cancer.